# Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

> **NCT06964620** · EARLY_PHASE1 · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 84 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Sanggua tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06964620
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2027-11-24
- **Final completion:** 2027-12-25
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06964620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06964620, "Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06964620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*